PepGen Company Top Insiders

PEPG Stock  USD 5.36  0.01  0.19%   
PepGen's insiders are aggressively buying. The analysis of the overall insider sentiment regarding PepGen suggests that almost all insiders are extremely bullish. PepGen employs about 56 people. The company is managed by 20 executives with a total tenure of roughly 131 years, averaging almost 6.0 years of service per executive, having 2.8 employees per reported executive.
Insider Sentiment
Aggressively Buying
 
Selling
 
Buying

Latest Trades

2025-09-30Science Enterprises Plc OxfordAcquired 200000 @ 3.2View
2025-05-30Paul StreckAcquired 8375 @ 1.24View
2025-04-17James G McarthurAcquired 10000 @ 1.35View
2025-04-08James G McarthurAcquired 41500 @ 1.15View
Monitoring insider sentiment in PepGen can give investors another window into how people closest to the business may be assessing current prospects. The stronger workflow is to compare insider behavior with earnings, guidance, and business changes instead of reading the transactions in isolation.

Management Team Effectiveness

The company has return on total asset (ROA) of -36.03 % which means that for every $100 of assets, it generated a loss of $36.03. This is well below the sector average. Similarly, it shows a return on stockholder's equity (ROE) of -67.39 %, which implies that it generated no returns to current stockholders.
As of last month (February 2026), Common Stock Shares Outstanding is forecasted to soften to approximately 28.4 M. In addition to that, Net Loss is projected to grow to approximately -59.1 M.

Stock Institutional Investors

About 92.48% of PepGen is held by institutions, with insiders at 0.71%. Current market capitalization is about 369.77 Million. This split helps separate index-driven activity from active bets. The business currently sits in the Health Care sector and the Pharmaceuticals, Biotechnology & Life Sciences industry. Watching turnover and volume trends alongside ownership data adds depth to the picture.
Shares
Woodline Partners Lp2025-12-31
1.3 M
Awm Investment Company Inc2025-12-31
1.3 M
Deep Track Capital, Lp2025-09-30
1.2 M
Tcg Crossover Management, Llc2025-09-30
1.2 M
Balyasny Asset Management Llc2025-12-31
866.3 K
Perceptive Advisors Llc2025-09-30
829.9 K
Logos Global Management Lp2025-09-30
750 K
Siren, L.l.c.2025-12-31
700 K
Octagon Capital Advisors Lp2025-12-31
700 K
Ra Capital Management, Llc2025-12-31
20.1 M
Viking Global Investors Lp2025-12-31
3.5 M
At 369.77 Million, PepGen sits in smaller-cap territory where institutional context matters most alongside valuation and volatility readings. The business currently sits in the Healthcare sector and the Biotechnology industry. Shares outstanding are near 69.1 M. Comparing institutional flows with insider activity and short interest builds a fuller picture for a smaller-cap like PepGen.

Insider Trading Activities

Insider activity around PepGen deserves attention because officers, directors, and large shareholders usually see shifts in operating momentum before the market fully prices them. Current market capitalization is about 369.77 Million. Used properly, these records are better for context than for blind buy-or-sell signals.

Outstanding Bonds

Outstanding bonds linked to PepGen can tell investors a great deal about how the company finances itself beyond common equity markets. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.

Corporate Filings

13A
11th of March 2026
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
6th of March 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
4th of March 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
2nd of March 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
18th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
10th of December 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
8th of December 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of November 2025
An amended filing to the original Schedule 13G
ViewVerify
The majority of PepGen's outstanding shares are owned by institutions. This level of institutional concentration typically reflects the stock's inclusion in major indices, consistent liquidity, and long-term investment attractiveness for funds managing assets on behalf of pensions, endowments, and other institutional clients. With institutions controlling the majority of the float, changes in quarterly 13F filings can provide meaningful signals about shifts in professional investor sentiment. The ownership breakdown for PepGen shows approximately 92% institutional, 1% insider, and 7% public.
 
Shares in Circulation  
 First Issued
2020-03-31
 Previous Quarter
32.7 M
 Current Value
68.8 M
 Average Shares Outstanding
25.6 M
 Quarterly Volatility
12.4 M
Macro event markers
 
Covid
 
Interest Hikes

Holders Distribution

Institutional ownership analysis for PepGen matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.

Market Cap and Value

Workforce Comparison

PepGen ranks fifth among stocks in number of employees across its competitive set. The total workforce of Health Care industry is at this time estimated at about 781. PepGen holds roughly 56.0 in number of employees claiming about 7% of equities under Health Care sector.

Insider Trading History

The insider-trading timeline for PepGen gives investors a long-run view of how management behavior has tracked against the stock's price action. Shares outstanding are near 69.1 M. Because insider trades are publicly filed, the record is useful for verifying alignment between what management says and what they do with their own capital.
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
1.6667
10
6
1,862,805
9,238
2025-12-01
1.0909
12
11
2,388,807
2,025,917
2025-03-01
6.0
12
2
698,157
2,959
2024-09-01
0.6429
9
14
273,314
60,996
2024-06-01
1.0909
12
11
106,169
49,004
2023-06-01
1.0
10
10
88,250
62,500
2023-03-01
1.25
10
8
670,392
12,784
2022-12-01
2.0
2
1
32,686
10,000
2022-06-01
1.087
25
23
11,414,041
9,465,282

Notable Stakeholders

Stakeholder analysis for PepGen is useful because companies often face trade-offs among groups that want very different outcomes from the same business. Used properly, stakeholder review helps investors stay aware of the people and incentives that may be shaping key decisions behind the scenes.
James McArthurCEO and PresidentProfile
Caroline GodfreyFounder MemberProfile
MBA CFASenior CommunicationsProfile
JD EsqChief OfficerProfile
Afsaneh MohebbiSenior ManagementProfile
Michelle MDSenior DevelopmentProfile
David CFASenior CommunicationsProfile
Jaya GoyalExecutive DevelopmentProfile
MD MBAExecutive DevelopmentProfile
Kasra KasraianChief OfficerProfile
Hayley ParkerSenior AffairsProfile
Sonia DPHILVP OperationsProfile
Michael GaitFounder MemberProfile
Jennifer CormierVP OperationsProfile
Mary DeLenaGeneral SecretaryProfile
Mary JDGeneral SecretaryProfile
Kyle BreidenstineVP ControllerProfile
Emiko BryantSenior AdministrationProfile
Noel MBAChief OfficerProfile
Niels SvenstrupManufacturing ChemistryProfile

Management Information & Data Sources

PepGen is a small-cap company in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Executive review focuses on insiders, senior management, and employee signals. Leadership review helps frame whether management actions match reported operating results. CEO is James McArthur with 56 employees and 20 reported executives.

Reported values for PepGen are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Sell-side coverage, where present, supplements the data shown. Refresh times depend on source availability. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 4th, 2026

Workforce Efficiency and Productivity

Workforce efficiency at PepGen can help investors judge how effectively labor resources are being converted into revenue and profit over time. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

PepGen Manpower Efficiency

Return on PepGen Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.6M
Net Loss Per Executive4.5M
Working Capital Per Employee2.5M
Working Capital Per Executive6.9M

Popular Tools for PepGen Stock analysis

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges